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Abstract: Increased maspin expression in the colon is related to colon cancer risk and patient 
survival. Maspin is induced by the hydrophobic bile acid, deoxycholate (DOC), which is an 
endogenous carcinogen and inducer of oxidative stress and DNA damage in the colon. Persistent 
exposure of colon epithelial cells, in vitro, to high physiologic levels of DOC results in increased 
constitutive levels of maspin protein expression associated with the development of apoptosis 
resistance. When an apoptosis-resistant colon epithelial cell line (HCT-116RC) developed in 
the authors’ laboratory was treated with a maspin-specific siRNA probe, there was a statisti-
cally significant increase in apoptosis compared to treatment with an siRNA control probe. 
These results indicate, for the first time, that maspin is an anti-apoptotic protein in the colon. 
Immunohistochemical evaluation of maspin expression in human colonic epithelial cells during 
sporadic colon carcinogenesis (131 human tissues evaluated) indicated a statistically significant 
increase in maspin protein expression beginning at the polyp stage of carcinogenesis. There was 
no statistically significant difference in maspin expression between hyperplastic/adenomatous 
polyps and colonic adenocarcinomas. The absence of “field defects” in the non-neoplastic 
colonic mucosa of patients with colonic neoplasia indicates that maspin may drive the growth 
of tumors, in part, through its anti-apoptotic function.
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Introduction
Colon carcinogenesis is associated with a high-fat diet1 and such a diet results in 
increased concentrations of endogenous bile acids in the gut.2–4 Although numerous bile 
acids are released from the gallbladder into the small intestine, only the hydrophobic 
bile acids are particularly damaging to cells.1 The hydrophobic bile acids, deoxycholic 
acid, and lithocholic acid, resulting from bacterial metabolism, are the predominant bile 
acids found in the human colon. Thus, in previous work, the authors explored the effects 
of exposure of cells of colonic origin to high pathophysiologic concentrations of deoxy-
cholate (DOC). It was shown that repeatedly exposing HCT-116 colon epithelial cells 
to increasing concentrations of DOC over months resulted in the development of cells 
with apoptosis resistance,5 a hallmark of cancer.6,7 Apoptosis resistance during colon 
carcinogenesis is a major process associated with the survival of cells with genomic 
instability.8–11 2D-gel electrophoresis/matrix-assisted laser desorption/ionization 
(MALDI)-mass spectroscopy of these apoptosis-resistant cells indicated, unexpectedly, 
that maspin was one of the proteins that was substantially upregulated.5
Maspin is a 42 kDa protein with high sequence homology to members of the 
serpin peptidase inhibitor family of proteins.12,13 Early experimental results with Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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maspin in mammary tissue indicated that it acts as a tumor 
suppressor.14,15 However, maspin does not undergo the 
S (stressed) to R (relaxed) conformational transition that char-
acterizes active serpins.16,17 Thus, the mechanisms by which it 
exerts its tumor suppressor activity have been actively sought. 
One of the mechanisms proposed to explain the tumor-
suppressive functions of maspin in noncolon-derived cells is 
that it sensitizes cells to apoptosis,18–25 thereby preventing the 
clonal expansion of preneoplastic cells with DNA damage. 
In contrast to mammary tissue, maspin expression in colon 
epithelial tissue appears to be related to increased colon 
cancer risk and reduced patient survival.26–31 High maspin 
expression is associated with neoplastic transformation and 
high tumor grade.
It was determined, using small interfering RNA 
(siRNA) technology, that maspin is an anti-apoptotic pro-
tein in colon epithelial cells, which can explain the asso-
ciation of increased maspin expression with increased 
risk of colon   carcinogenesis. Human colonic tissues were 
screened, using immunohistochemical analysis, to deter-
mine if maspin was differentially expressed during colon 
  carcinogenesis. Maspin’s first increased expression occurred 
at the   hyperplastic/adenomatous polyp stage of colon 
  tumorigenesis. No evidence of “field defects” with respect 
to maspin expression was observed in the non-neoplastic 
mucosa of patients with polyps or adenocarcinomas. The role 
of maspin as a “double-edged sword” during colon carcino-
genesis is discussed in the light of these new findings.
Materials and methods
sirnA methodology
Potential siRNA probes were identified by Dr Seth Ririe, 
Senior Technical Service Scientist (QIAGEN, Inc, Valencia, 
CA) by scanning the mRNA nucleotide sequence for human 
maspin (GenBank Accession #NM_002639) using QIAGEN 
Software. Three siRNA probes were selected to have the 
highest potential for success based on siRNA design (QIA-
GEN, Inc). A BLAST (Basic Local Alignment Search Tool 
[designed by scientists at the NIH]) search was performed 
on these three oligonucleotide sequences, and the 19-mer 
sequence that was very specific with homology only to maspin 
mRNA (3′-dTdTGUCACACUUGCUGGUCUGG-5′) was 
chosen for the siRNA experiments. This sequence started 
at nucleotide #528 of the human maspin mRNA sequence 
(GenBank Accession #NM_002639). An siRNA control 
probe was provided by QIAGEN that does not target any 
known human gene. HCT-116RC colon epithelial cells were 
selected for the siRNA experiments, as it was one of the 
three resistant cell lines that was developed in the authors’ 
laboratory after persistent exposure of HCT-116 parental 
cells to increasing concentrations of the   hydrophobic bile 
acid, DOC, for a period of ∼40 weeks.5 This cell line became 
stably resistant to apoptosis induced by 0.5 mM DOC and 
maintained a high level of maspin expression (sodium 
DOC was obtained from Sigma Aldrich [St Louis, MO]). 
The stability of this cell line as to apoptosis resistance and 
high maspin expression was ensured in the present siRNA 
experiments by including 0.5 mM DOC as a negative control. 
The HCT-116RC cells were plated in 24-well Falcon poly-
styrene tissue culture dishes (Fisher   Scientific, Pittsburgh, 
PA) at a concentration of 1 × 105 cells/mL, and treated with 
either 0.8 µg maspin-specific siRNA probe, 0.8 µg siRNA 
control probe, 0.5 mM DOC, or control media for 24 hours. 
(SiRNA treatments for 48 hours decreased cell viability, as 
determined using trypan blue exclusion.) All wells contained 
the TransMessenger Transfection Reagent (TTR) from QIA-
GEN. The ratio of siRNA to TTR was 1:5 (µg:µL). A total 
of ten experiments were used to analyze for the induction 
of apoptosis by the siRNA probes.
Assessment of apoptosis in sirnA 
experiments
Cytospins were prepared of all experimental groups: 
(1) untreated control or treated with (2) DOC, (3) siRNA, 
or (4) control siRNA, and stained with Giemsa stain. A total 
of ten siRNA experiments were included to assess statisti-
cal significance. One hundred cells were counted from each 
prepared slide and the percentage of apoptosis assessed using 
standard morphologic criteria.8,32
Briefly, apoptotic cells can be identified by bright-field 
microscopy using the following criteria in various stages of 
the apoptotic process: condensation of the chromatin (deep 
purple to black stain intensity), fragmentation of the nucleus 
into round discrete chromatin masses, increase in cytoplasmic 
blebbing, and the formation of apoptotic bodies.
Western blot analyses
Western blot procedures were performed as previously 
described.33,34 Cells were grown in 20 × 50 mm Falcon poly-
styrene tissue culture dishes. Cultures treated with DOC 
or siRNA probes or cells incubated in control media were 
disrupted in lysis buffer (50 mM Tris pH 8, 5 mM EDTA, 
150 mM NaCl, 0.5% NP-40) supplemented with 1 mM 
phenylmethylsulfonyl fluoride (PMSF), leupeptin (1 µg/mL), 
and aprotinin (0.01 U/mL). Cell lysates were prepared at a 
concentration of 2 µg/µL of protein and a total of 20 µg of Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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protein was added to each well of a 15% Criterion   Tris-HCl 
gel (Bio-Rad, Hercules, CA) for size fractionation by 
  electrophoresis. The proteins were blotted onto   Immobilon-P 
  polyvinylidene fluoride (PVDF) transfer membranes 
(  Millipore, Bedford, MA). The membranes were incubated 
with mouse antihuman maspin antibody (catalog #554292; 
BD Biosciences Pharmingen, San Jose, CA) at a dilution 
of 1:1000. The membranes were then incubated with goat 
antimouse secondary antibodies conjugated to horseradish 
peroxidase (Thermo Scientific, Rockford, IL). Antibody 
complexes were detected using the SuperSignal West Pico 
chemiluminescence detection system (Thermo Scientific). 
Finally, the membranes were stained for 20 minutes with 
  Brilliant Blue G dye (Sigma-Aldrich, St Louis, MO) to 
confirm equal protein loading, as previously described.33,34 
  Brilliant Blue G dye was chosen to stain the membranes rather 
than a specific protein as a loading control since Brilliant 
Blue staining evaluates numerous bands found in the entire 
gel33,34 whereas the evaluation of a specific protein can be 
  misleading. This approach is based on work published from 
the authors’ laboratory using GAPDH and G3PD,35 and 
the results of Qi and Sit36 who screened 22 housekeeping 
genes and found a large number to be modulated by various 
experimental conditions. In addition, the cytoskeletal protein, 
β-actin, has been reported not to be a reliable loading control 
in Western blot analysis.37 Even F-actin has been reported to 
be experimentally modulated as evidenced by the decomposi-
tion of F-actin in apoptosis experiments.38
The Western blot experiments were repeated at least three 
times; in the repeats, separate cultures were treated and cell 
lysates were separately prepared. The band intensities after 
siRNA and DOC treatments were then compared with control 
cells (no siRNA, no DOC) using automated densitometry 
(Image-Pro software package, v 5.1.1.38; Media   Cybernetics, 
Silver Spring, MD), and the values normalized to control 
values. Two replicates from each lysate were also run to 
ensure technical reproducibility.
Procurement of human colon tissues
A total of 131 tissue samples was procured for this study 
with informed consent according to procedures approved by 
the institutional review boards at the University of Arizona 
(supervises human subject studies at University Medical 
Center [UMC] and the Southern Arizona Veterans Affairs 
Health Care System [SAVAHCS]) and the Tucson Medical 
Center (TMC). All tissue samples (n = 106) from colon resec-
tions (16 patients [two normal, two diverticulitis, seven with 
sporadic adenocarcinomas, four with large adenomas, one 
with ulcerative colitis/adenocarcinoma]) were obtained in 
the operating room at UMC. In the resected colon segment, 
samples of the non-neoplastic mucosa were taken adjacent 
to the tumor on the proximal and distal sides (P0, D0), 2 cm 
away on the proximal and distal side (P2, D2) and near the 
surgical margins (PMAX, DMAX). These tissue samples 
were fixed immediately in formalin by CMP and HH, as previ-
ously described.39–41 All colonoscopy tissue samples (n = 10) 
from five patients without colonic disease were obtained at 
UMC and at SAVAHCS under the direct supervision of CB 
and fixed immediately in formalin, as previously described.42 
Tissue samples from archived biopsies of polyps/adenomas 
(n = 8, including two hyperplastic polyps, six adenomatous 
polyps), and colon cancers (n = 7) were obtained from TMC 
and selected for the present study by GW.
immunohistochemical procedures
Four micron sections of each paraffin block were prepared, 
immersed in xylene and rehydrated through a series of 
ethanols. Antigen retrieval was achieved using Vector AR 
(Vector Laboratories, Burlingame, CA) in a microwave and 
endogenous peroxidase blocked with 30% H2O2 (Sigma-
Aldrich). Background Sniper from a Mach 3 (Biocare 
Medical, Concord, CA) kit was applied followed by mouse 
antihuman maspin antibody (catalog #554292; BD Biosci-
ences Pharmingen), the secondary antibody (polyclonal 
rabbit antimouse biotinylated antibody [catalog #E0413; 
DAKO, Glostrup, Denmark]), and then by Vector PK6100 
(Vectastain ABC kit; Vector Laboratories, Burlingame, CA) 
and 3,3′-diaminobenzidine (Sigma-Aldrich). Slides were 
counterstained with freshly filtered hematoxylin, dehydrated 
through a graded series of ethanols, immersed in xylene, 
and mounted using Cytoseal Mounting Medium (VWR, 
Tempe, AZ), as previously described.42,43
scoring of immunohistochemical results
The intensity of the maspin stain (light to dark brown color) 
and extent of the tissue expressing the maspin stain were 
taken into consideration using the immunohistochemical 
procedures described above. Slides were scored for maspin 
expression using a scale of  0 to +4.0. Since maspin expres-
sion was shown to be high in ulcerative colitis (UC),28 a case 
of  UC from the authors’ archived colon tissue bank was used 
as a positive control for this study. The associated adenocar-
cinoma from this UC case was strongly positive and received 
a score of +4. A more complete description of this positive 
control (with images) is described in Results. Slides that 
received no primary antibody served as the immunocontrol Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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in each experimental run, and consistently had a score of 
zero (no brown stain). No tissues in the study that received 
the maspin antibody had a score of zero. Tissues with a blush 
of maspin staining were given a score of 0.5. The rest of 
the tissues were given a score of 1, 2, 3 or 4, relative to the 
strongly positive UC control tissues (ranged from 2 to 4). 
Epithelial cells near lymphoid follicles often expressed 
increased maspin. This immunostaining pattern was observed 
in both control samples and in the non-neoplastic mucosa of 
patients with colonic tumors; such immunostaining was not 
evaluated in the scoring of the tissues.
statistical analyses
Individual densitometric scan values from experimental 
groups in Western blots, apoptosis percentages from siRNA 
experiments, and maspin immunostaining scores from human 
tissue groups were entered into spreadsheets using Microsoft 
Office Excel 2007 (Microsoft, Redmond, WA) software. The 
following parameters were assessed for each experimental 
group: average, standard deviation, and standard error of 
the mean.   Differences in mean values between experimen-
tal groups were considered statistically significant at the 
95% confidence level using Student’s t-test. Actual P values 
are reported in the study.
Photography
Digital images were obtained with 4× and 20× Nikon objec-
tives using a Nikon Eclipse E400 (Nikon, Tokyo, Japan) 
bright-field microscope equipped with a Moticam 2300 
(Motic®, Xiamen, China) 3.0 megapixel camera using Motic 
Images Plus (v 2.0; Motic) digital imaging software.
Results
Maspin proven to be an anti-apoptotic 
protein in colon epithelial cells in vitro 
based on sirnA strategies
To determine if the reduction in maspin induced apoptosis, 
the apoptosis-resistant HCT-116RC cells were exposed 
to a maspin-specific antisense 19-mer oligonucleotide probe 
(3′-dTdTGUCACACUUGCUGGUCUGG-5′), and to a con-
trol siRNA probe for 24 hours and compared with control 
cells (no siRNA, no DOC) and cells treated with 0.5 mM 
DOC. (The control cells received only the TransMessenger 
Transfection Reagent (TTR) without any siRNA probe or 
DOC; the DOC-treated cells in TTR media served as a control 
for the stability of the resistant state of the cells.) Treatment 
of cells with the maspin-specific siRNA probe resulted in a 
statistically significant increase in apoptosis when compared 
with: (1) control cells (P = 3.29 × 10−5), (2) cells treated with 
DOC (P = 9.58 × 10−5), and (3) cells treated with a control 
siRNA probe (P = 4.57 × 10−3) (Figure 1). The control siRNA 
probe showed a statistically significant increase in apopto-
sis when compared with control cells (P = 9.05 × 10−3) and 
DOC-treated cells (P = 9.14 × 10−3). DOC treatment did not 
show an increase in apoptosis compared with control cells 
(P = 0.173).
To ensure that the maspin siRNA knocked down the pro-
tein expression level of the 42 kDa maspin protein, the same 
treatment of cells as above was performed, and Western blots 
from each treatment group were probed with a monoclonal 
antibody for maspin (Figure 2A). A densitometric analysis 
(Figure 2B) indicated that treatment of cells with the maspin-
specific siRNA resulted in a significant (P = 7.8 × 10−3) reduc-
tion in maspin protein expression compared with untreated 
control cells. There was no significant reduction in maspin 
expression using the control siRNA (P = 0.272) or the DOC 
treatment (P = 0.437).
In conclusion, the use of a specific maspin siRNA probe 
resulted in an approximately 20% reduction in maspin 
protein levels, which had a significant effect on the induc-
tion of   apoptosis. These findings indicate that maspin was 
responsible, in part, for the observed resistance of the HCT-
116 cells.
immunohistochemical evaluation of a 
case of UC as a positive control for 
maspin expression
Since maspin expression is reported to be high in the non-
neoplastic mucosa and associated adenocarcinomas from 
patients with inflammatory bowel disease,28 a case of UC 
from the authors’ tissue archives was included as a positive 
control for the present immunohistochemical studies on spo-
radic colon cancers. Tissue from the cancer and 13 regions 
of the non-neoplastic colonic mucosa (PMAX, P3, P2, P0, 
D0, D2, D3, D4, D5, D6, D7, D8, D9) was immunostained 
for maspin and the intensity of expression scored on a scale 
of 0 to +4.0. Representative bright-field microscopic images 
displaying maspin expression are shown in Figure 3. The 
adenocarcinoma displayed the highest expression of maspin 
(score of +4) (see Figure 3, Panel F), with abundant nuclear 
maspin staining in addition to cytoplasmic staining. Twelve 
of the non-neoplastic tissue samples received a score of +3 
and one received a score of +2. All 130 tissue samples from 
patients with polyps/sporadic colon cancer and from patients 
with no evidence of colonic neoplasia in the present study 
were compared with this positive control.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 1 HCT-116RC cells treated with either control media, 0.5 mM DOC (deoxycholate), control siRNA, or maspin-specific siRNA for 24 hours and the percentage 
of apoptosis ± SEM determined for each experimental group. The single asterisk indicates statistically significant differences compared to untreated cells in control media. 
Treatment of cells with 0.5 mM DOC served as a control to ensure that the cells had maintained their apoptosis resistance to the same apoptosis-inducing agent that was used 
to develop the resistant cells over ∼40 weeks of persistent exposure. There was no significant increase in the % apoptosis after treatment of cells with 0.5 mM DOC.
Notes: *Control siRNA treatment resulted in significantly more apoptosis than control cells and DOC-treated cells; **Maspin siRNA treatment resulted in significantly more 
apoptosis than both control cells and DOC-treated cells; #% apoptosis induced by the specific maspin siRNA probe was significantly higher than that produced by the siRNA control.
Abbreviations: siRNA, small interfering RNA; SEM, standard error of the mean; DOC, deoxycholate.
immunohistochemical evaluation of 
maspin expression in human tissues 
during colon cancer progression
Progression to colon cancer proceeds by means of numerous 
changes in the colonic mucosa, progressing from normal 
tissue to “field defects” in the non-neoplastic flat mucosa, 
to hyperplastic polyps, to adenomatous polyps (adenomas), 
and, ultimately, to colon cancer. A total of 131 representative 
tissues from the authors’ colon tissue banks was screened 
and the intensity and pattern of maspin expression at each 
of these stages was compared.
The colonic mucosa from patients with no evidence 
of colonic neoplasia exhibits a low expression of 
maspin
Multiple tissue samples of colonic mucosa were obtained from 
patients without colonic neoplasia. These tissue samples were 
from resected colon segments obtained during surgery and 
from biopsies obtained during colonoscopy. Two patients had 
a recurrent sarcoma removed that was external to the colon 
wall. To prevent further possible recurrences of the sarcoma, 
the surrounding tissues, including a segment of colon, were 
removed. Neither patient received radiation or chemotherapy 
prior. Two patients had diverticulitis that required the removal 
of the involved colon segment. Five patients with no evidence 
of colonic lesions had two biopsies of the colonic mucosa taken 
during routine colonoscopy. An immunohistochemical evalua-
tion of maspin expression indicated low expression of maspin 
(score of 0.5 or 1) in these 35 tissue samples (Table 1). There was 
some variability in the pattern of maspin expression (Figure 4), 
but all colonic tissues showed some focal or diffuse maspin 
expression in the cytoplasm of the epithelial cells. The low 
overall expression in the colonic crypts is shown in Figure 4A, 
D, and E. The low overall staining predominantly at the top of 
the crypts is shown in Figure 4C and F. Focal distinct staining in 
individual cells of the crypts is shown in Figure 4B. There was 
no statistical difference (P = 0.91) (Table 1) in maspin expres-
sion between the colonoscopy specimens (Figure 4A and B) and 
the non-neoplastic tissue samples from the colon resections of 
patients with no colonic neoplasia (Figure 4C–F).Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 2 (A) Western blots of maspin expression from hCT-116rC cells treated 
with 0.5 mM DOC, sirnA control probe, or sirnA maspin probe for 24 hours. 
(B) relative protein expression levels were obtained using densitometry. DOC 
treatment was used as an internal control to ensure that the resistant cells still 
maintained the same high level of maspin expression and could not be further 
induced by DOC. routine staining of the entire gel with Brilliant blue indicated that 
all lanes received the same amount of protein.
Note: *reduction in maspin protein levels after incubation with the specific siRNA 
maspin probe was statistically significant compared with untreated control cells 
(P = 0.0078).
Abbreviations: siRNA, small interfering RNA; SEM, standard error of the mean; 
DOC, deoxycholate.
Colon resections from patients with colonic tumors 
and evaluation of “field defects”
Tissue samples (n = 106) from non-neoplastic colonic mucosa, 
adenomas, and adenocarcinomas present in the resected colon 
segments obtained at surgery were immunostained for maspin, 
and a relative score of 0, 0.5 (minimal staining), 1, 2, 3, or 4 
was assigned to each of these tissues (Table 2). Non-neoplastic 
tissues in resected colon segments that harbored a tumor (in ten 
patients) were scored to identify possible “field defects” asso-
ciated with maspin expression. Samples of the non-neoplastic 
mucosa were taken adjacent to the tumor on the proximal and 
distal sides (P0, D0), 2 cm away on the proximal and distal 
side (P2, D2) and near the surgical margins (PMAX, DMAX). 
The adenomas/adenocarcinomas displayed a maspin score 
that was ∼3 times (2.17/0.66) greater than the maspin score 
in tissue samples taken from non-neoplastic colonic mucosa 
present in the same colon resection (Figure 5). The overall 
mean maspin expression in the adenomas/adenocarcinomas 
was significantly increased compared with the mean maspin 
expression in the non-neoplastic colonic mucosa in the same 
resected tissues (P = 0.00002) (Table 3), and significantly 
increased over that of control colonic mucosa from patients 
with no colonic neoplasia (P = 0.00004) (Table 3). There was 
no significant difference between the non-neoplastic colonic 
mucosa of patients with a colonic neoplasia (Table 2) and 
the colonic mucosa of patients with no colonic neoplasia 
(Table 1).
It is interesting that the non-neoplastic mucosa of the 
UC patient, shown in Figure 3, exhibited a high expression 
of maspin (2.92 ± 0.28), which was significantly greater 
(P = 7.52 × 10−16) than the mean (0.66 ± 0.20) of the non-
neoplastic mucosa of patients with sporadic adenomas/
adenocarcinomas (Table 2). This comparison of images of 
non-neoplastic mucosa from inflammatory bowel disease 
(Figure 3) and sporadic colon cancer (Figure 4) underscores 
the different etiologies of these two diseases. This will be 
briefly discussed in the discussion section.
high expression of maspin begins at the polyp/
adenoma stage of sporadic colon carcinogenesis
Since high maspin expression was not observed as “field 
defects” in the 61 samples of non-neoplastic colonic mucosa 
obtained from colon resections of patients with large sporadic 
adenomas or adenocarcinomas, maspin expression was evalu-
ated in a number of early colonic growths, which included 
hyperplastic and adenomatous polyps, to determine if high 
maspin expression was characteristic of the polyp stage of 
colon cancer progression (Table 4). Statistically increased 
maspin expression occurred at the polyp stage (Table 4) 
compared with the non-neoplastic mucosa of control patients 
(Table 1) (P = 9.10 × 10−13) and the non-neoplastic mucosa 
adjacent to hyperplastic polyps and adenomatous polyps 
(P = 8.37 × 10−7) (Table 4). There was no statistical differ-
ence in maspin expression of polyps compared with that of 
adenocarcinomas (P = 0.43) (Table 3). Images of maspin 
expression in non-neoplastic mucosa from control subjects 
and from patients with colonic tumors are shown in Figure 4. 
The non-neoplastic colonic mucosa immediately adjacent to 
polyps was also evaluated for maspin expression (Table 4) 
and it was determined that there was no significant differ-
ence in maspin expression compared with the non-neoplastic 
colonic mucosa of control subjects (Table 1) (P = 0.18) and 
that of the non-neoplastic colonic mucosa at some distance 
from colonic tumors (Table 2) (P = 0.44). Images of polyps 
and adjacent non-neoplastic mucosa are shown in Figure 6. 
Therefore, it appears that increased expression of maspin 
is associated with the formation of a tumor at the earli-
est macroscopic stage of tumor growth visible on routine 
colonoscopy.
Discussion
Previous work from the authors’ laboratory indicated that 
persistent exposure of apoptosis-sensitive colon epithelial Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 3 Composite of images of colonic tissue from a patient with ulcerative colitis and adenocarcinoma stained for maspin expression. (A) non-neoplastic mucosa taken 
adjacent to the cancer on the proximal side. (B) non-neoplastic mucosa taken adjacent to the cancer on the distal side. (C) non-neoplastic mucosa taken 3 cm away from 
the cancer on the proximal side. (D) non-neoplastic mucosa taken 9 cm away from the cancer on the distal side. (E) Higher magnification of representative non-neoplastic 
mucosa taken 3 cm away from the cancer on the distal side; note the predominately cytoplasmic staining of maspin. (F) note the increased overall expression of maspin in 
the adenocarcinoma; prominent nuclear staining of maspin is evident.
Notes: images A–D were taken with a 4× objective lens; images E and F were taken with a 20× objective lens; all images counterstained with hematoxylin.
cells to DOC, a hydrophobic bile acid, for ∼40 weeks led to 
the selection of cells that were stably resistant to DOC.5 These 
resistant cells were characterized at the molecular and cellular 
levels to understand some of the pathways and key proteins 
that may have been modulated to account for their resistance 
to apoptosis.5,33,34,44–46 In one study, two-dimensional gel elec-
trophoresis and mass spectroscopy of the HCT-116RC cell 
line, revealed a dramatic increase in maspin protein expres-
sion.5 The DOC-induced maspin expression may have been 
the result of DOC-induced DNA damage and/or oxidative 
stress, since the maspin promoter contains binding sites for 
major transcription factors that respond to DNA damage 
and/or oxidative stress, such as NF-kappaB,47,48 SP1,49,50 
p53,51–53 ATF-2,54 and NKX3-155 (Figure 7).Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 1 Maspin expression in the colonic mucosa of patients with no colonic polyps, cancer or inflammatory bowel disease
Patients 1a 2 3 4 5 6 7 8 9 10 Mean maspin   
expression
normal colon resection 1  
(sarcoma patient)
0.5 0.5 0.5 0.5 0.5 0.5 0.5 –b – – 0.50 ± 0
normal colon resection 2  
(sarcoma patient)
0.5 0.5 1 1 0.5 – – – – – 0.70 ± 0.27
Diverticulitis patient 1 0.5 1 1 1 1 1 – – – – 0.92 ± 0.20
Diverticulitis patient 2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 – – – 0.50 ± 0
Colonoscopy biopsies 0.5 0.5 0.5 0.5 0.5 0.5 1 0.5 1 1 0.65 ± 0.24
Notes: Mean overall maspin expression of control tissues = 0.64 ± 0.23; atissue sample; bno tissue available.
Maspin is a multifunctional protein whose expression 
in different anatomic locations may affect different aspects 
of carcinogenesis.56 Although maspin acts as a tumor sup-
pressor in the breast and has a pro-apoptotic role in that 
tissue, the authors have shown for the first time that maspin 
acts as an anti-apoptotic protein in colon epithelial cells. 
This may explain its role as a stress-response protein in 
the colon (Figure 7), since cells need to evade cell death so 
that oxidative DNA damages can be adequately repaired.10 
In fact, knockout of both maspin genes is embryonically 
lethal,57 indicating its importance to cell survival or function. 
However, extended upregulation of anti-apoptotic proteins 
can have deleterious consequences. Apoptosis-resistant cells 
that harbor unrepaired DNA damages and enter the pool of 
proliferating cells may propagate mutations, some of which 
may lead to cancer58,59 (Figure 7).
The mechanisms by which maspin inhibits apoptosis in 
the colon are not known.
The maspin protein has 8 cysteines60 and exists in several 
molecular configurations that are dependent upon degree of 
oxidative stress and the extent of intramolecular disulfide 
bridge formation.61 In addition to the generation of oxidative 
stress, reactive oxygen species can have physiological effects 
on cells because of their ability to positively or negatively 
affect protein function,62 thereby affecting different signaling 
pathways63,64 (Figure 7). Since maspin can interact with at 
least 20 different molecules,56 the effect of oxidative stress 
on maspin and the downstream maspin–protein interactions 
can ultimately affect cell survival and carcinogenesis. Since 
caspases have cysteines as a critical amino acid affecting 
their pro-apoptotic function,65 it is possible that maspin may 
physically interact with and inhibit caspases through disulfide 
bridge formation (Figure 7). Studies in different cell types 
indicate that maspin can interact with specific proteins that 
may reduce cellular stresses and cell death, such as glutathi-
one S-transferase (GST)66 and heat shock protein 70 (HSP70) 
(Figure 7).66 GST is a major antioxidant defense protein that 
protects epithelial cells in aberrant crypt foci from DOC-
induced apoptosis,67 and the activity of GST is increased 
by its interaction with maspin.66 HSP70 serves to protect 
against cell death since it sequesters apoptosis-inducing 
factor (AIF) in the cytoplasm,68–73 thereby preventing the 
translocation of AIF to the nucleus and binding to DNA.74,75 
When translocation of AIF to the nucleus occurs, it induces 
DNA condensation and the recruitment of endogenous endo- 
and exonucleases, resulting in DNA fragmentation.76,77 The 
signaling pathways that lead to apoptosis are most complex, 
and maspin may interfere, through physical interactions, 
with the action or activity of apoptosis regulatory proteins 
(Figure 7). The survival of cells depends not only on inhibit-
ing pro-cell death pathways, but the activation of prosurvival 
pathways. Since the authors previously reported that the 
NF-κB and autophagy pathways are constitutively activated 
and contributed to the survival of the resistant HCT-116RC 
cells,5,33 maspin may also interact with key proteins in these 
prosurvival pathways (Figure 7). A full understanding of 
maspin’s role as an anti-apoptotic protein will benefit from 
technologies such as yeast 2-hybrid analyses, co-immuno-
precipitations, cDNA microarrays, proteomic analyses and 
transmission electron microscopy after siRNA knockdown, 
and confocal microscopy for organelle localizations under 
different experimental conditions.
To understand maspin’s role in colon carcinogenesis, an 
immunohistochemical analysis of maspin expression was 
performed in the epithelial cells of macroscopically normal 
colonic mucosa, polyps, adenomas and adenocarcinomas. 
It was found that maspin is highly expressed at the polyp 
and adenocarcinoma stages of colon carcinogenesis, which 
is consistent with others’ results.29 High maspin expres-
sion, however, was not observed as “field defects” in the 
non-neoplastic colonic mucosa,78 either directly adjacent 
to a tumor or at different distances proximal or distal to 
the tumor. In contrast, “field defects” were observed in the 
decreased expression of the DNA repair proteins Pms2, Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 4 Variability in maspin expression in non-neoplastic colonic mucosa obtained from normal subjects and patients with colonic tumors (4× objective). (A) normal 
mucosa obtained from a healthy patient during routine colonoscopy. This image shows a low overall expression of maspin; (B) normal mucosa obtained from a healthy 
patient during routine colonoscopy. This image shows focal staining in individual cells (arrows); (C) normal mucosa obtained from a colon resection from a patient who had 
a sarcoma surgically removed. The sarcoma was external to the body wall and the patient had received no prior radiation or chemotherapy. This image shows low overall 
staining predominantly at the top of the crypts (arrows); (D) region of colon 2 cm proximal to a large tubulovillous adenoma. This image shows a low overall expression of 
maspin; (E) region of colon 2 cm proximal to a large tubulovillous adenoma. This image shows a low overall expression of maspin; (F) region of colon near the distal margin 
of a colon resection from a patient with a colon cancer. This image shows low overall staining predominantly at the top of the crypts (arrows).
Table 2 Maspin expression in non-neoplastic colonic mucosa and tumors in colonic resections of patients with sporadic adenomas 
and adenocarcinomas
Patient category PMAX P2 P0 Adenoma/Cancer D0 D2 DMAX
TVA 0.5 1 – 3 0.5 1 0.5
TVA 0.5 0.5 0.5 1 0.5 0.5 0.5
TVA 1 0.5 0.5 3 0.5 0.5 1
Adenoma/CA 0.5 0.5 1 3/2 0.5 2 –
Adenoma/CA 0.5 0.5 0.5 2/2 0.5 0.5 0.5
Adenocarcinoma 0.5 0.5 0.5 3 0.5 0.5 0.5
Adenocarcinoma – 1 0.5 2 1 0.5 0.5
Adenocarcinoma 1 1 2 3 1 0.5 1
Adenocarcinoma 1 1 0.5 1 0.5 0.5 1
Adenocarcinoma – 0.5 0.5 1 0.5 – 0.5
Mean score ± sD 0.69 ± 0.26 0.70 ± 0.26 0.72 ± 0.51 2.17 ± 0.83 0.6 ± 0.21 0.72 ± 0.51 0.67 ± 0.25
Notes: samples of the non-neoplastic mucosa were taken adjacent to the tumor on the proximal and distal sides (P0, D0), 2 cm away on the proximal and distal side (P2, D2) 
and near the surgical margins (PMAX, DMAX). 
Abbreviations: CA, carcinoma; DMAX, maximum distance from the tumor at the distal margin of the resection; PMAX, maximum distance from the tumor at the proximal 
margin of the resection; SD, standard deviation; TVA, tubulovillous adenoma.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 5 histogram displaying the average maspin score ± sEM in the non-neoplastic mucosa at different distances from the colonic neoplasms of 10 patients with a large 
adenoma (A) or cancer (CA). samples of the non-neoplastic mucosa were taken adjacent to the tumor on the proximal and distal sides (P0, D0), 2 cm away on the proximal 
and distal side (P2, D2) and near the surgical margins (PMAX, DMAX). 
Abbreviation: sEM, standard error of the mean.
Table 3 Mean maspin expression in non-neoplastic colonic mucosa of colon resections from patients with and without colonic 
neoplasia: comparison to mean maspin expression of adenomas and adenocarcinomas
Control colonic mucosa from patients  
without colonic neoplasia (n = 9)
Non-neoplastic colonic mucosa from patients  
with colonic neoplasia (n = 10)
Adenomas/Adenocarcinomas 
(n = 12)
0.65 ± 0.20 0.66 ± 0.20 2.17 ± 0.83
student’s t-test P = 0.931 P = 0.000022 
P = 0.000043
Notes: 1Non-significant difference in mean maspin expression compared with control colonic mucosa; 2significant difference in maspin expression compared with non-
neoplastic colonic mucosa from patients with colonic neoplasia; 3significant difference in maspin expression compared with control colonic mucosa.
ERCC1, Xpf, and Ku86,41,79 and in an apoptosis-related 
mitochondrial   protein, cytochrome c oxidase.40,42 It is 
possible that a dramatic and sustained increase in maspin 
expression at the polyp stage may drive sporadic colon 
tumorigenesis through its anti-apoptotic function and 
interaction with other survival signaling pathways in the 
colon. The anti-apoptotic function of maspin might also 
allow cells in a field of genomic instability within polyps 
and adenocarcinomas to proliferate and undergo further 
clonal expansion (Figure 7).
Although DOC was previously thought to be a promoter 
of colon cancer, the authors have previously documented that 
DOC is a true carcinogen.80 The authors found that prolonged 
dietary feeding of DOC to mice (to produce the colonic 
level of DOC found in the colons of humans on a high-fat 
diet) was responsible for the formation of both adenomas81 
and adenocarcinomas80 in the mouse proximal colon. The 
DOC-induced increase in maspin expression previously 
documented5 may explain the increase in maspin expression 
in ampullary adenocarcinomas that occur near the ampulla of 
Vater,82 through which copious amounts of bile are released 
into the small intestine (see endoscopy image in Rana et al83). 
DOC contained in the secreted bile may be responsible for 
the formation of these rare adenocarcinomas that occur in 
the small intestine.
An interesting question has emerged from the authors’ 
studies concerning the role of maspin expression dur-
ing colon carcinogenesis. Since maspin expression first 
appears significantly increased at the polyp stage of spo-
radic colon carcinogenesis, but is significantly increased in 
the non-neoplastic mucosa of patients with inflammatory 
bowel disease, what is the role of inflammation in sporadic 
colon cancer? An increase in maspin expression as a “field 
defect” was not observed in the colon of patients with Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Table 4 Comparison of maspin expression in hyperplastic polyps, 
adenomatous  polyps,  adenocarcinomas  and  non-neoplastic 
mucosa
Polyps Adenocarcinomas Non-neoplastic mucosa  
adjacent to polyps
3* 3 3
1* 2 0.5
3* 2 1
2* 3 0.5
3 1 0.5
3 2 0.5
3 1 0.5
3 1 0.5
2 3 0.5
3 3 0.5
2 2 0.5
2 4 0.5
1 2 0.5
0.5 1
0.5
3
Mean ± sD =  
2.38 ± 0.77
Mean ± sD =  
2.11 ± 1.00
Mean ± sD =  
0.88 ± 0.85
Note: *Large adenomas from colon resections.
Abbreviation: sD, standard deviation.
D
A
C
B
Figure 6 increased maspin expression in polyps (brown color) compared with minimal expression in adjacent non-neoplastic colonic mucosa (see arrows). (A) Adenomatous 
polyp; (B) adenomatous polyp; (C) hyperplastic polyp; (D) adenomatous polyp (4× objective).
sporadic colon cancer, and distinct areas of inflammatory 
infiltrates, as observed in UC, were absent in the tissues 
examined in the present study. There appear to be mul-
tiple pathways to colon cancer, including inherited genetic 
mutations, inflammatory conditions of the colon (eg, UC, 
Crohn’s disease), and a high-fat/low-vegetable diet. The 
development of sporadic colon cancer appears to result, in 
large part, from dietary factors. Since increased hydropho-
bic bile acids are associated with a high fat diet, persistent 
exposure to these bile acids over decades can induce multiple 
stresses on colon cells, causing DNA damage, oxidative/
nitrosative stress, and mitotic perturbations,34,46,84–90 resulting 
in the gradual selection of clones with a growth advantage 
(Figure 7). The increase in maspin at the polyp stage in 
sporadic colon cancer may then reflect the proliferation of 
persistently stressed clones of cells. Since maspin is clearly 
a stress-response protein, it is possible that it responds to 
specific stresses associated with the polyp stage of colon 
carcinogenesis, which may be accentuated by a decrease in 
key DNA repair proteins, for example. Since the tissues of 
the polyps/cancers with high maspin expression also do not 
show an apparent inflammatory infiltrate, the association 
between maspin and inflammation in sporadic colon cancer 
cannot be made in the present study. In inflammatory bowel 
disease, large areas of the colon may be in a “highly stressed 
state,” as a result of multiple deleterious factors secreted 
from inflammatory cells, resulting in persistently increased 
maspin expression (and increased apoptosis resistance) in 
the non-neoplastic mucosa. The normal mucosa of patients 
with UC can harbor significant DNA damage, oxidative Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Figure 7 Molecular signaling pathways that may be activated after persistent exposure of cells to hydrophobic bile acids. since hydrophobic bile acids can perturb cellular 
membranes, surface molecules can be activated that generate reactive oxygen and nitrogen species. This can cause oxidative DnA damage and the activation of genes 
associated with the stress response and the activation of transcription factors that turn on genes associated with cell survival. These survival genes include maspin, classic 
anti-apoptotic genes that are nF-κB-activated, and autophagy-related genes, such as beclin. in order for cells with DnA damages to proliferate, they must evade cell death 
pathways. Maspin may inhibit these pro-apoptotic pathways through interaction with proteins (eg, GsT, hsP70) known to interact with maspin and to inhibit apoptosis. Future 
studies, designated by question marks, indicate possible interactions with apoptosis regulatory proteins, caspases (executioners of apoptosis) and proteins associated with the 
pro-survival nF-κB and autophagic pathways. some of these potential maspin-target protein interactions may result in activation or inhibition of the target proteins.
Abbreviations: ATF-2, activating transcription factor 2; GST, glutathione S-transferase; HSP70, heat shock protein 70; NF-κB, redox-sensitive transcription factor; NFKB1, 
nuclear factor nF-κB p105 subunit; NKX3-1, product of the homeobox gene that functions as a transcription factor; p53, tumor protein 53; RNS, reactive nitrogen species; 
ROS, reactive oxygen species; SP1, transcription factor that responds to physiological and pathological stimuli.
damage, and even mutations in cancer-related oncogenes,91,92 
a situation that may increase the probability of development 
of neoplasia under these severe inflammatory conditions.
In future studies, it will be important to understand the 
mechanisms by which maspin functions as an anti-apoptotic 
protein, and to determine its role in early preneoplastic 
lesions. It may also serve as a biomarker to evaluate colon 
cancer risk and tumor progression, perhaps in conjunction 
with other biomarkers, such as increased 8-oxoguanine and 
loss of DNA repair proteins.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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